Diuretics for cardiovascular prevention in the elderly

被引:0
|
作者
O Hanon
M-L Seux
H Lenoir
A-S Rigaud
X Girerd
F Forette
机构
[1] Hôpital Broca,Department of Geriatrics
[2] Hôpital de la Pitié Salpêtrière,Department of Endocrinology—Cardiovascular Prevention Unit
来源
关键词
diuretics; cardiovascular prevention; elderly;
D O I
暂无
中图分类号
学科分类号
摘要
High blood pressure (BP) is a major risk factor for cardiovascular and cerebrovascular diseases in elderly subjects. Antihypertensive drugs have shown clinical benefit both in primary and secondary prevention of cardiovascular events. If BP lowering represents the major determinant of the effects conferred by the antihypertensive treatment for prevention, recent studies have suggested some differences between classes of antihypertensive drugs according to age. Based on the available clinical data, the recent medical guidelines have recommended thiazide-type diuretics as the preferred drug for the treatment of elderly hypertensive patients, followed by long-acting calcium antagonists. Indeed, diuretics constitute one of the most valuable classes of antihypertensive drugs, and in the elderly, diuretic-based treatment studies have been clearly shown to prevent major cardiovascular events, including stroke, heart failure and coronary heart disease.
引用
收藏
页码:S15 / S22
相关论文
共 50 条
  • [31] Prevention of cardiovascular events in elderly hypercholesterolemic patients
    Bruckert E.
    Current Atherosclerosis Reports, 1999, 1 (1) : 9 - 15
  • [32] Aspirin for the primary prevention of cardiovascular disease in the elderly
    O'Sullivan, Jack W.
    BMJ EVIDENCE-BASED MEDICINE, 2019, 24 (04) : 143 - 144
  • [33] Prevention of cardiovascular diseases in elderly subjects with hyperlipidaemia
    Bruckert, E
    Giral, P
    THERAPIE, 2000, 55 (06): : 669 - 674
  • [34] Dyslipidemia and prevention of atherosclerotic cardiovascular disease in the elderly
    Lucchi, Tiziano
    MINERVA MEDICA, 2021, 112 (06) : 804 - 816
  • [35] Primary Prevention of Cardiovascular Disease with Statins in the Elderly
    Željko Reiner
    Current Atherosclerosis Reports, 2014, 16
  • [36] Aspirin in primary prevention of cardiovascular disease in the elderly
    Galli, Mattia
    Andreotti, Felicita
    D'Amario, Domenico
    Vergallo, Rocco
    Montone, Rocco A.
    Porto, Italo
    Crea, Filippo
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (05) : 326 - 327
  • [37] Cardiovascular disease in the elderly: prevention and treatment strategies
    Musumeci, Giuseppe
    Mihalcsik, Laurian
    Rossini, Roberta
    Staffiere, Elio
    Fiocca, Luigi
    Lortkipanidze, Nikoloz
    Vattimo, Francesco
    Guagliumi, Giulio
    Gavazzi, Antonello
    Valsecchi, Orazio
    GIORNALE ITALIANO DI CARDIOLOGIA, 2010, 11 (11) : 33S - 36S
  • [38] Is it time for a cardiovascular primary prevention trial in the elderly?
    Robinson, Jennifer G.
    Bakris, George
    Torner, James
    Stone, Neil J.
    Wallace, Robert
    STROKE, 2007, 38 (02) : 441 - 450
  • [39] Primary prevention of cardiovascular diseases in the elderly population
    Panarelli, Roberta
    Caputo, Cosima
    Cavino, Giovanna
    Scarpa, Antonio
    Giordano, Lucia
    Palmiero, Pasquale
    ITALIAN JOURNAL OF MEDICINE, 2024, 18 (02)
  • [40] Is it worth offering cardiovascular disease prevention to the elderly?
    Gohlke, Helmut
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2013, 20 (01) : 121 - 126